Psychiatry and Neurology, Neurology · Boston, MA
NPI
1346200698
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
Beth Israel Deaconess Med. Ctr., 330 Brookline Avenue; Room Cls-638
Boston, MA, 02215
Phone (617) 735-3251
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
756 services
Medicare patients, 2024
162
Average age 75
Drug cost, 2024
$680K
1,342 prescriptions
Company payments, 2024
$39.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David K Simon was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 161 times for 105 patients. In total David K Simon billed 756 services in 24 codes, and Medicare paid $43K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 161 | 105 | $13.62 | $2,192 |
| 99215 Office E&M - Established | Facility | 152 | 99 | $112.05 | $17K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 105 | 47 | $25.63 | $2,692 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 53 | 33 | $13.52 | $716 |
| 99214 Office E&M - Established | Facility | 51 | 34 | $71.73 | $3,658 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 22 | $65.38 | $3,269 |
| 99215 Office E&M - Established | Office | 30 | 22 | $149.46 | $4,484 |
| 95983 Electrical Nerve Conductivity | Facility | 23 | 12 | $37.61 | $865 |
| 99214 Office E&M - Established | Office | 17 | 13 | $87.81 | $1,493 |
By year: 2022 $37K for 501 services; 2023 $36K for 481 services; 2024 $43K for 756 services.
Medicare prescription drug claims, 2024
In 2024, the drug David K Simon prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 349 prescriptions and refills. In total David K Simon wrote 1,342 Medicare prescriptions that cost $680K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 349 | 960 | 106 | $19K |
| Rytary Carbidopa/Levodopa | 151 | 303 | 31 | $320K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 113 | 321 | 40 | $14K |
| Rasagiline Mesylate Generic | 106 | 302 | 30 | $18K |
| Amantadine Amantadine Hcl | 68 | 180 | 25 | $3,922 |
| Entacapone Generic | 58 | 165 | 20 | $21K |
| Donepezil Hcl Generic | 55 | 140 | 13 | $1,329 |
| Rivastigmine Rivastigmine Tartrate | 39 | 108 | 15 | $3,440 |
| Clonazepam Generic | 38 | 50 | Under 11 | $562 |
| Ongentys Opicapone | 24 | 52 | Under 11 | $32K |
| Nuplazid Pimavanserin Tartrate | 22 | 22 | Under 11 | $111K |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 20 | 60 | Under 11 | $8,617 |
| Zonisamide Generic | 19 | 29 | Under 11 | $260 |
| Escitalopram Oxalate Generic | 19 | 57 | Under 11 | $356 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 16 | 49 | Under 11 | $381 |
Brand drugs: 285 claims; generic drugs: 1,057 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid David K Simon $39.18 ($39.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $39.18.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $39.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.